HCM Q3 2017 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q3 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$57M+2.7% YoY

Gross Profit

-$8M-13.8% margin

Operating Income

-$19M-32.6% margin

Net Income

-$14M-24.8% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

-54.7%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$15M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$598M

Total Liabilities

$113M

Stockholders' Equity

$462M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57M	$56M	+2.7%
Gross Profit	-$8M	-$5M	-58.2%
Operating Income	-$19M	-$15M	-21.5%
Net Income	-$14M	$6M	-354.6%